Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Frequently asked questions
What sector does Cannabix Technologies Inc (BLO) operate in?
Cannabix Technologies Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Cannabix Technologies Inc (BLO) current stock price?
As of the latest data, Cannabix Technologies Inc stock price is CA$0.52, with a previous close of CA$0.53. Cannabix Technologies Inc lost -CA$0.01 in the last trading session, representing a -1.89% loss.
What is Cannabix Technologies Inc (BLO) current market capitalization?
Cannabix Technologies Inc market cap is approximately 63.88 million.
What is Cannabix Technologies Inc (BLO) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.05.
Does Cannabix Technologies Inc (BLO) pay dividends?
No. Cannabix Technologies Inc does not pay a dividend.
What is Cannabix Technologies Inc (BLO) beta (volatility) score?
Cannabix Technologies Inc has a beta of 1.539, suggesting it is more volatile than the market.
